AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

The United States doubled down on its decades-old support for Taiwan as China flexed its muscles with a second day of ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

Global investors' interest in China's capital markets is also rebounding. A recent report by Goldman Sachs noted that ...

China's president Xi Jinping recently held a meeting with 40 leaders of multinational companies, including BMW and ...

They include Rajesh Subramaniam of FedEx, Bill Winters of Standard Chartered, Paul Hudson of Sanofi, and Pascal Soriot of ...

German investment in China’s auto industry has been one of the few bright spots as foreign investment has slowed to a crawl.

Spain ranks first in Europe for clinical trials and is attracting investment in life sciences, but faces intense competition ...

China's president Xi Jinping recently held a meeting with 40 leaders of multinational companies, including BMW and ...